pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Classification of e-cigarettes by countries or jurisdictions

Classification Countries or jurisdictions
Tobacco products, tobacco-related products, tobacco imitation, tobacco derivatives, or tobacco surrogates (61 countries or jurisdictions) Albania, Argentina, Austria, Azerbaijan, Bahrain, Brunei Darussalam, Bulgaria, Colombia, Costa Rica, Croatia, Ecuador, England, Estonia, Finland, Georgia, Germany, Greece, Greenland, Guam, Honduras, Indonesia, Iran, Italy, Latvia, Lithuania, Maldives, Malta, Mauritius, Mexico, Moldova, Montenegro, Nepal, Netherlands, New Zealand, Nicaragua, Niue, Northern Ireland, Norway, Palau, Panama, Paraguay, Poland, Republic of Korea, Romania, Scotland, Senegal, Seychelles, Singapore, Slovakia, Slovenia, Spain, Sweden, Tajikistan, Togo, Turkey, Turkmenistan, United States, Uzbekistan, Venezuela, Vietnam, and Wales

Medicines, drugs, or medical devices (24 countries or jurisdictions) Australia, Austria, Belgium, Canada, Chile, Denmark, England, Estonia, Finland, France, Iceland, Ireland, Jamaica, Japan, Northern Ireland, Norway, Philippines, Scotland, South Africa, Sweden, Thailand, United States, Venezuela, and Wales

Consumer products, devices, or combination products (25 countries or jurisdictions) Australia, Bangladesh, Canada, England, France, Germany, Greece, Hungary, Iceland, Ireland, Malaysia, Moldova, Mongolia, Netherlands, Northern Ireland, Pakistan, Republic of Korea, Scotland, Sudan, Switzerland, United States, Vanuatu, Venezuela, Wales, and Yemen

Electronic nicotine delivery systems (ENDS), e-cigarettes, or vaping products (77 countries or jurisdictions) Albania, Argentina, Austria, Azerbaijan, Bahrain, Barbados, Belgium, Brazil, Bulgaria, Cambodia, Canada, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, England, Estonia, Fiji, Finland, France, Gambia, Germany, Greece, Guam, India, Ireland, Israel, Italy, Jamaica, Jordan, Kuwait, Lao People’s Democratic Republic, Latvia, Lebanon, Lithuania, Luxembourg, Malta, Moldova, Montenegro, Nepal, Netherlands, New Zealand, Northern Ireland, Norway, Oman, Panama, Paraguay, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Scotland, Serbia, Slovakia, Slovenia, Spain, Sri Lanka, Suriname, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Timor-Leste, Turkey, Turkmenistan, Uganda, Ukraine, United Arab Emirates, Uruguay, Uzbekistan, and Wales

Poisons or hazardous substances (2 countries or jurisdictions) Brunei Darussalam and Malaysia
Korean J Clin Pharm 2022;32:133-43 https://doi.org/10.24304/kjcp.2022.32.2.133
© 2022 Korean J Clin Pharm